endpoints.news is our new home on June 1. endpts.com will still work, but the front door is now https://endpoints.news

Pharma channel feed

Te­va CEO says Auste­do can grow 'way be­yond' im­pact of IRA

3 months ago

Trump ad­min­is­tra­tion makes first com­ments on how it will run IRA drug ne­go­ti­a­tions

3 months ago
FDA+

Key GOP sen­a­tor is ‘strug­gling’ with Kennedy nom­i­na­tion over vac­cine an­swers

3 months ago
People
FDA+

Ahead of earn­ings, Lil­ly culls mid-stage drug for heart fail­ure and chron­ic kid­ney dis­ease

3 months ago
R&D

As­traZeneca and Dai­ichi Sanky­o's En­her­tu ap­proved in 'ul­tralow' HER2 pa­tients

3 months ago
FDA+

Ozem­pic la­bel ex­pand­ed to in­clude re­duced risk of wors­en­ing kid­ney dis­ease

3 months ago
FDA+

No­vo Nordisk asks Third Cir­cuit to ex­pe­dite IRA case as par­tic­i­pa­tion dead­line looms

3 months ago
Law

Sarep­ta shares two-year DMD study da­ta that could in­form Eu­ro­pean ap­proval de­ci­sion

4 months ago
R&D
FDA+

Phar­ma­cy mid­dle­men lose bid to toss new Hawaii com­plaint

4 months ago
Law

Pfiz­er inks $60M set­tle­ment to close Nurtec an­ti-kick­back suit

4 months ago
Law

Sage turns down Bio­gen's buy­out of­fer and will look at oth­er op­tions

4 months ago
Deals

Bris­tol My­ers shares IO com­bo da­ta in col­orec­tal can­cer; Pfiz­er still wait­ing on Braftovi reg­i­men sur­vival fig­ures

4 months ago
R&D

Trump blog: Fed­er­al agen­cies must give jobs back to fired pro­ba­tion­ary work­ers, judge rules

4 months ago
FDA+
In Focus

Ei­sai and Bio­gen win ap­proval for once-month­ly Leqem­bi main­te­nance dos­ing

4 months ago
FDA+

Mer­ck and Ei­sai re­veal late-stage fail for Keytru­da and Lenvi­ma in gas­troe­sophageal can­cer

4 months ago
R&D

Take­da dis­con­tin­ues US sup­ply of gout drug Uloric over gener­ic com­pe­ti­tion 

4 months ago
Manufacturing

As­traZeneca al­lo­cates $570M for Cana­di­an ex­pan­sion, looks to add 700 new jobs

4 months ago
R&D

As an­oth­er Trump term gets un­der­way, phar­ma ad­vi­sors get com­fort­able with un­cer­tain­ty

4 months ago
FDA+

Te­va, Astel­las plan to par­tic­i­pate in IRA drug price ne­go­ti­a­tions

4 months ago
FDA+

Pur­due, Sack­lers reach new $7.4B opi­oid set­tle­ment af­ter SCO­TUS re­jec­tion

4 months ago
Law

Te­va’s MS drug and gener­ics to add black box warn­ing for ana­phy­lax­is

4 months ago

As­traZeneca ex­ec stress­es Calquence's patent life ahead of next Medicare ne­go­ti­a­tions

4 months ago
FDA+

Van­da los­es con­sti­tu­tion­al fight over FDA's drug talks with com­peti­tors

4 months ago
FDA+
Law

J&J re­in­forces Caply­ta block­buster pro­jec­tions, won't shelve neu­ro prospects

4 months ago
First page Previous page 16171819202122 Next page Last page
A service from the Financial Times